ClassID:

20209

A61K31/105 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Sulfur, selenium, or tellurium compounds, e.g. thiols Persulfides

Recent Application in this class:
#1
20260083687
2026-03-26

COMPOUNDS FOR REDUCING LACTATION AND IMPROVING HEALTH

#2
20240335417
2024-10-10

COMPOSITIONS AND METHODS FOR ENHANCING SEXUAL PLEASURE AND PERFORMANCE

#3
20230277550
2023-09-07

Methods for Treating Respiratory Diseases Characterized by Mucus Hypersecretion

#4
20230110087
2023-04-13

IPA-3-loaded liposomes and methods of use thereof

#5
20220233579
2022-07-28

HYDROGEN SULFIDE RELEASING POLYMER COMPOUNDS

#6
20220125743
2022-04-28

Formulation for inhibiting formation of 5-HT2B agonists and methods of using same

#7
20220009796
2022-01-13

Water turbine that captures ionic surfactants of the water from polluted rivers and seas using mantle periodotite carbon mineralization based activated carbon for purification

#8
20210393550
2021-12-23

Formulation for inhibiting formation of 5-HTagonists and methods of using same

#9
20210386778
2021-12-16

Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D

#10
20210353589
2021-11-18

WATER SOLUBLE COMPOSITIONS COMPRISING PURIFIED CANNABINOIDS

#11
20210330752
2021-10-28

FEED SUPPLEMENTS

#12
20210308098
2021-10-07

WATER SOLUBLE COMPOSITIONS COMPRISING PURIFIED CANNABINOIDS

#13
20210308097
2021-10-07

Water soluble compositions comprising purified cannabinoids

#14
20210275617
2021-09-09

Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression

#15
20210267916
2021-09-02

Formulation for inhibiting formation of 5-HTagonists and methods of using same

#16
20210186894
2021-06-24

IPA-3-loaded liposomes and methods of use thereof

#17
20210108228
2021-04-15

Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles

#18
20210100862
2021-04-08

Therapeutic cannabis extracts

#19
20210100751
2021-04-08

PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF

#20
20210023065
2021-01-28

AMPHIPHILIC THIOL COMPOUNDS AND USES THEREOF

#21
20210000791
2021-01-07

Water soluble compositions comprising purified cannabinoids

#22
20210000504
2021-01-07

Medical implant delivery device

#23
20200297659
2020-09-24

METHODS OF DIAGNOSIS AND TREATMENT INVOLVING NITRITE

#24
20200253924
2020-08-13

Water soluble compositions comprising purified cannabinoids

#25
20200246281
2020-08-06

Formulation for inhibiting formation of 5-HT2B agonists and methods of using same

#26
20200197465
2020-06-25

Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression

#27
20200171041
2020-06-04

Methods and therapeutics to regulate hydrogen sulfide bioavailability

#28
20200138773
2020-05-07

COMPOSITIONS AND METHODS FOR ENHANCING SEXUAL PLEASURE AND PERFORMANCE

#29
20200038342
2020-02-06

FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY

#30
20200009107
2020-01-09

Compositions and methods for enhancing sexual pleasure and performance

#31
20190298756
2019-10-03

Hydrogen sulfide releasing polymer compounds

#32
20190216745
2019-07-18

Formulations of a transdermal patch for pain management

#33
20190183853
2019-06-20

Water soluble compositions comprising purified cannabinoids

#34
20190169122
2019-06-06

Compositions and methods for treatment of prostate carcinoma

#35
20190083424
2019-03-21

Formulation for inhibiting formation of 5-HTagonists and methods of using same

#36
20180369163
2018-12-27

Antibacterial S-heterosubstituted disulfides

#37
20180360773
2018-12-20

Process for the manufacture of ajoene derivatives

#38
20180271802
2018-09-27

Methods of diagnosis and treatment involving nitrite

#39
20180142261
2018-05-24

Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes

#40
20180133170
2018-05-17

METHODS AND COMPOSITIONS FOR TREATING DISORDERS

#41
20170360720
2017-12-21

METHOD TO SUPPLEMENT HUMAN IMMUNE SYSTEM IN SUPPRESSING HSV SYMPTOMS

#42
20170258741
2017-09-14

Fatty acid cysteamine conjugates and their use as activators of autophagy

#43
20170173059
2017-06-22

Novel Combination of Naturally Occurring Compounds to Assist With Suspected Mycobacterial Infections Related to Autoimmune Conditions

#44
20170071876
2017-03-16

Cyanide antidote compositions and methods of use

#45
20170056337
2017-03-02

Antibacterial S-heterosubstituted disulfides

#46
20160374944
2016-12-29

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CANCER BY TARGETING AND INHIBITING CANCER STEM CELLS

#47
20150359815
2015-12-17

PAK1 INHIBITION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

#48
20150335663
2015-11-26

Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction

#49
20150327547
2015-11-19

N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents

#50
20150297535
2015-10-22

Formulations of dimethyl trisulfide for use as a cyanide antidote

#51
20150290323
2015-10-15

DIALKYL TRISULFIDES AND FORMULATIONS OF DIALKYL TRISULFIDES FOR USE AS A CYANIDE ANTIDOTE

#52
20150290143
2015-10-15

Dimethyl trisulfide as a cyanide antidote

#53
20150182492
2015-07-02

Ulcer treatment

#54
20140323562
2014-10-30

THIOSULFINATE ANTIOXIDANTS AND METHODS OF USE THEREOF

#55
20140303070
2014-10-09

PROCESS FOR THE MANUFACTURE OF AJOENE DERIVATIVES

#56
20140235565
2014-08-21

-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents

#57
20140107222
2014-04-17

TREATMENTS FOR SOCIAL LEARNING DISORDERS

#58
20130338225
2013-12-19

Compounds as L-cystine crystallization inhibitors and uses thereof

#59
20130315844
2013-11-28

Oral care compositions

#60
20130171104
2013-07-04

SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITIZATION OF TUMOR CELLS

#61
20130129809
2013-05-23

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CANCER BY TARGETING AND INHIBITING CANCER STEM CELLS

#62
20130059869
2013-03-07

METHODS AND COMPOSITIONS FOR TREATING DISORDERS

#63
20120282334
2012-11-08

PROCESS FOR PREPARING AJOENE FROM GARLIC

#64
20120148690
2012-06-14

SKIN BARRIER FUNCTION RECOVERY ACCELERATOR

#65
20120071349
2012-03-22

Anti-aging agents and methods to identify them

#66
20110212082
2011-09-01

METHOD FOR PRODUCING TABLET COMPRISING NATURAL ALLICIN

#67
20110190368
2011-08-04

Organosulfur compounds, a method of making organosulfur compounds and their use for inhibiting the growth of tumour cells

#68
20110177173
2011-07-21

Compounds as L-cystine crystallization inhibitors and uses thereof

#69
20110065772
2011-03-17

TREATMENT OF RHEUMATOID ARTHRITIS

#70
20110052568
2011-03-03

Tablet comprising natural allicin and method for producing the same

#71
20100260733
2010-10-14

Anti aging agents and methods to identify them

#72
20100204337
2010-08-12

Antibacterial S-heterosubstituted disulfides

#73
20100130555
2010-05-27

Compositions and methods for treating or preventing hypoxic or ischemic injury

#74
20100099757
2010-04-22

DISULFIRAM DOSES AND TREATMENT REGIMEN SUITABLE FOR TREATMENT OF ANGIOGENESIS-DEPENDENT DISORDERS

#75
20100099737
2010-04-22

COMPOSITIONS AND METHODS FOR TREATING MYELOSUPPRESSION

#76
20100048676
2010-02-25

Non-androgen dependent roles for androgen receptor in liver cancer

#77
20090239817
2009-09-24

ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS

#78
20090232827
2009-09-17

Compositions and methods of use of compounds to increase cancer patient survival time

#79
20090143377
2009-06-04

Methods and compositions for treating disorders

#80
20080193498
2008-08-14

Chemoprotective methods

#81
20080182815
2008-07-31

Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents

#82
20080102142
2008-05-01

METHOD OF USING AJOENE AS ALCOHOL DEHYDROGENASE INHIBITOR, COMPOSITION FOR REMOVING HANGOVER COMPRISING AJOENE AND METHOD OF PREPARING THE SAME

#83
20080070839
2008-03-20

Composition and method for treating cancer

#84
20070196866
2007-08-23

Modulators of ion channel trpa1

#85
20070184047
2007-08-09

Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction

#86
20070031520
2007-02-08

Method of using ajoene as alcohol dehydrogenase inhibitor, composition for removing hangover comprising ajoene and method of preparing the same

#87
20060205824
2006-09-14

Chiral integrin modulators and methods of use thereof

#88
20060135453
2006-06-22

Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes

#89
14550108
2018-04-24

Composition for the treatment of acne